Pharmacology and Therapeutics of Asthma and COPD (Handbook of Experimental Pharmacology)
Book file PDF easily for everyone and every device.
You can download and read online Pharmacology and Therapeutics of Asthma and COPD (Handbook of Experimental Pharmacology) file PDF Book only if you are registered here.
And also you can download or read online all Book PDF file that related with Pharmacology and Therapeutics of Asthma and COPD (Handbook of Experimental Pharmacology) book.
Happy reading Pharmacology and Therapeutics of Asthma and COPD (Handbook of Experimental Pharmacology) Bookeveryone.
Download file Free Book PDF Pharmacology and Therapeutics of Asthma and COPD (Handbook of Experimental Pharmacology) at Complete PDF Library.
This Book have some digital formats such us :paperbook, ebook, kindle, epub, fb2 and another formats.
Here is The CompletePDF Book Library.
It's free to register here to get Book file PDF Pharmacology and Therapeutics of Asthma and COPD (Handbook of Experimental Pharmacology) Pocket Guide.
Not in United States? Choose your country's store to see books available for purchase. See if you have enough points for this item. Sign in. The present volume is supposed to be a major reference resource for chest physicians and those involved in the development of novel pharmaceutical entities for these diseases. Internationally recognized authorities review the most important new information on the advances in our understanding of the pathogenesis and treatment of these diseases, including the substantial advances in the topical delivery of inhaled medicines.
Each chapter is extensively referenced, generously illustrated with clear diagrams and photographs, and represents a state-of-the-art review of this important area of respiratory medicine. Textbook of Nephro-Endocrinology. Gordon H. Bone Cancer. Elsevier Science. Williams Hematology, 9E. Kenneth Kaushansky. William H. David G. Hematologic Malignancies. Bouthaina Dabaja. Hemostasis and Thrombosis. Victor J. Alan D. Clinical Malignant Hematology. Mikkael A.
Renal Pharmacotherapy. Larry K Golightly. The Autoimmune Diseases. Ian R. Pediatric Liver Tumors. Marcio Malogolowkin. Heart Physiology and Pathophysiology. Yoshihisa Kurachi. Muscle 2-Volume Set. Joseph Hill. Drug-Induced Liver Disease. Neil Kaplowitz. Visual Dysfunction in Diabetes.
Joyce Tombran-Tink. Neoplastic Diseases of the Blood. John M. Introduction to Cancer Metastasis. Aamir Ahmad. Diabetic Retinopathy. Elia Duh. Treatment of Multiple Myeloma and Related Disorders. Vincent Rajkumar. Oxford Textbook of Oncology. David J. Psoriatic Arthritis and Psoriasis. Adewale Adebajo. Colon and Other Gastrointestinal Cancers.
Vincent T. Heart Development and Regeneration. Nadia Rosenthal. Hepatocellular Carcinoma. Brian I. Drug Development. Timothy S. Recent Advances in Retinoblastoma Treatment. Jasmine H. Infection and Autoimmunity. Yehuda Shoenfeld. Bone Metastasis and Molecular Mechanisms. Gurmit Singh. Combination Treatment in Autoimmune Diseases.
Mechanisms and Models in Rheumatoid Arthritis. Pediatric Cancer, Volume 3. Cytokine-Induced Pathology. Brain Metastases from Primary Tumors, Volume 3. Studies on Atherosclerosis. Martin Rodriguez-Porcel. Rebecca C. Inflammation and Gastrointestinal Cancers. Janusz A. Chronic Leukemias and Lymphomas.
Gary J. Genetic Diseases of the Kidney. Richard P. Therapeutic Angiogenesis. Roberta A. Ertugrul Ercan. Tumors of the Central Nervous System, Volume 8. Eicosanoids in the Cardiovascular and Renal Systems. Advances in Immunity and Cancer Therapy. Fabry Disease. Deborah Elstein. Salpeter, S. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. Chest , — Singh, S. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Jama , — Suissa, S. Inhaled corticosteroids in COPD and the risk of serious pneumonia. Thorax 68 , — Rubin, B. Mucolytics, expectorants, and mucokinetic medications. Care 52 , — Li, Y. Adjuvant therapy efficacy of Chinese drugs pharmaceutics for COPD patients with respiratory failure: a meta-analysis. Rep Li, S. Effects of comprehensive therapy based on traditional Chinese medicine patterns in stable chronic obstructive pulmonary disease: a four-center, open-label, randomized, controlled study.
BMC Complement. Li, F. Randomized, double-blind, placebo-controlled superiority trial of the Yiqigubiao pill for the treatment of patients with chronic obstructive pulmonary disease at a stable stage. Li, J. Systems pharmacology-based dissection of mechanisms of Chinese medicinal formula Bufei Yishen as an effective treatment for chronic obstructive pulmonary disease. Shen, X.
Based Complement. Huang, C. Systems pharmacology in drug discovery and therapeutic insight for herbal medicines. Brief Bioinform. Barnes, P. Cellular and molecular mechanisms of chronic obstructive pulmonary disease. Chest Med. Alessandri, C. Hypercoagulability state in patients with chronic obstructive pulmonary disease. Chronic Obstructive Bronchitis and Haemostasis Group. Ganesan, S.
Rojas, D. Bhat, T. Pniewska, E. Exacerbating factors induce different gene expression profiles in peripheral blood mononuclear cells from asthmatics, patients with chronic obstructive pulmonary disease and healthy subjects. Allergy Immunol. Nakayama Wong, L. In Vitro 25 , — Morales, E.
Lynette Fernandes – Research Output — the UWA Profiles and Research Repository
Wong, S. Proteome Res. Roos, A. Targeting Interleukin signalling in cigarette smoke-induced lung disease: Mechanistic concepts and therapeutic opportunities. Ramos, F. Clinical issues of mucus accumulation in. Fahy, J. Airway mucus function and dysfunction. Burgel, P. Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium.
Thorax 59 , — Evans, C. Airway mucus: the good, the bad, the sticky. Chen, Y. Yaghi, A. Ciliary beating is depressed in nasal cilia from chronic obstructive pulmonary disease subjects. Alves Cde, F. The effects of proresolution of ellagic acid in an experimental model of allergic airway inflammation.
Mediators Inflamm. Antwi, A. Stigmasterol inhibits lipopolysaccharide-induced innate immune responses in murine models. Dinda, B. Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders. Negewo, N. COPD and its comorbidities: Impact, measurement and mechanisms. Respirology 20 , — Hirota, N. Mechanisms of airway remodeling.
Borvik, T. COPD and risk of venous thromboembolism and mortality in a general population. Ru, J. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. Su, X. Sietsema, W. The absolute oral bioavailability of selected drugs. Veber, D. Molecular properties that influence the oral bioavailability of drug candidates. Xu, X. A novel chemometric method for the prediction of human oral bioavailability. Toyoshima, H. The impact of side effects on hypertension management: a Japanese survey. Ma, C.
GPU accelerated chemical similarity calculation for compound library comparison. Model 51 , — Traditional Chinese medicine network pharmacology: theory, methodology and application. Yu, H. A systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data.
PLoS One 7 , e Zheng, C. Smoot, M. Cytoscape 2. Bioinformatics 27 , — Feng, W. Systems pharmacology reveals the unique mechanism features of Shenzhu Capsule for treatment of ulcerative colitis in comparison with synthetic drugs. Zheng, Y. Systems pharmacology-based exploration reveals mechanisms of anti-steatotic effects of Jiang Zhi Granule on non-alcoholic fatty liver disease.
Kanehisa, M. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. Dennis, G. Genome Biol. Bindea, G. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 25 , — Download references. All authors reviewed full-text manuscript for final revisions. Correspondence to Hong-Li Jiang. Reprints and Permissions.
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Advanced search. Skip to main content. Subjects Chronic obstructive pulmonary disease Clinical pharmacology. Introduction Chronic obstructive pulmonary disease COPD is a common preventable and treatable disease characterized by persistent respiratory symptoms and airflow limitation 1.
Table 1 Herbal components of Yihuo Huatan Formula. Full size table. Figure 1. Full size image. Figure 2. Figure 3. Figure 4. Figure 5. Discussion Adopting the systems pharmacology-based methods, we generally uncovered the working mechanism of YHF for stable COPD by exploring the crucial active compounds, targets and pathways Fig. Figure 6. Conclusions In conclusion, we provided systems pharmacology-based means to gain insights into the working mechanism of YHF for COPD by dissecting the bioactive compounds, potential targets and compounds-targets-diseases networks.
Active ingredients prediction In order to make the best use of high cost and time-consuming biological experiments and clinical research, the previous prediction to discover the potential active natural products from CHM formula is very necessary. Specifically, a combination of OB screening and DL property evaluation was applied to explore the active substance of YHF 38 Oral bioavailability calculation OB refers to the relative amount of the drug taken into the systemic circulation after extravascular administration Drug-Likeness calculation DL index refers to the structural similarity of the herbal ingredients to a known drug.
Data Availability Related materials and data included in our study are from open database resources which are available to public. References 1. Article Google Scholar 4. Article Google Scholar 5.